相关实验视频

Updated: Sep 13, 2025

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

艾滋病毒融入PTEN基因及其瘤微环境对肺癌的影响

Davey M Smith¹, Elizabeth F Rowland², Sara Gianella¹

¹Department of Medicine, University of California, San Diego, CA 92093, USA.

Current oncology (Toronto, Ont.)

|July 25, 2025

概括

人类免疫缺陷病毒 (HIV) 整合到PTEN基因中可能会导致艾滋病毒 (PWH) 感染者的肺癌. 这种融合与细胞扩张相结合,似乎减少了PTEN的表达,促进了瘤的生长.

科学领域:

在瘤学瘤学.
病毒学病毒学
遗传学是一个遗传学.

背景情况:

联合抗逆转录病毒疗法 (ART) 改善了艾滋病毒感染者 (PWH) 的健康结果.
然而,PWH仍然面临肺癌的高风险.
将艾滋病毒与癌症发展联系在一起的具体机制需要进一步研究.

研究的目的:

研究艾滋病毒整合在感染艾滋病毒的患者中小细胞肺癌的发展中的潜在作用.
分析艾滋病毒整合部位分布,克隆扩张和基因破坏.
评估与艾滋病毒感染和瘤进展相关的酸酶和素同源体 (PTEN) 的表达.

主要方法:

在血液,瘤和非瘤组织样本上进行了HIV整合部位测序.
分析包括集成站点分布和克隆扩张.
使用免疫光和显微镜评估PTEN表达.

主要成果:

确定了174个独特的HIV整合部位,其中29.9%在克隆扩展细胞中.
在克隆扩展细胞中,PTEN基因是最常见的整合部位 (4.2%16.7%).
在瘤组织和艾滋病毒p24抗原的区域中,PTEN表达显著降低.

结论:

艾滋病毒融入PTEN基因可能有助于PWH肺癌的发展.
艾滋病毒感染细胞的克隆扩张和随后的PTEN下调可能会损害抗瘤免疫力并促进癌症的进展.

关键词:

艾滋病病毒艾滋病病毒艾滋病病毒在这里,我们可以使用PTEN.克隆扩张的扩张.整合整合整合整合肺癌是一种肺癌.瘤微环境是一个微环境.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...